Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

784 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Protocol for a multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin versus standard therapy for the treatment of transverse myelitis in adults and children (STRIVE).
Absoud M, Gadian J, Hellier J, Brex PA, Ciccarelli O, Giovannoni G, Kelly J, McCrone P, Murphy C, Palace J, Pickles A, Pike M, Robertson N, Jacob A, Lim M. Absoud M, et al. Among authors: giovannoni g. BMJ Open. 2015 May 25;5(5):e008312. doi: 10.1136/bmjopen-2015-008312. BMJ Open. 2015. PMID: 26009577 Free PMC article. Clinical Trial.
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patients.
Leite MI, Coutinho E, Lana-Peixoto M, Apostolos S, Waters P, Sato D, Melamud L, Marta M, Graham A, Spillane J, Villa AM, Callegaro D, Santos E, da Silva AM, Jarius S, Howard R, Nakashima I, Giovannoni G, Buckley C, Hilton-Jones D, Vincent A, Palace J. Leite MI, et al. Among authors: giovannoni g. Neurology. 2012 May 15;78(20):1601-7. doi: 10.1212/WNL.0b013e31825644ff. Epub 2012 May 2. Neurology. 2012. PMID: 22551731 Free PMC article.
Time- and Region-Specific Season of Birth Effects in Multiple Sclerosis in the United Kingdom.
Rodríguez Cruz PM, Matthews L, Boggild M, Cavey A, Constantinescu CS, Evangelou N, Giovannoni G, Gray O, Hawkins S, Nicholas R, Oppenheimer M, Robertson N, Zajicek J, Rothwell PM, Palace J. Rodríguez Cruz PM, et al. Among authors: giovannoni g. JAMA Neurol. 2016 Aug 1;73(8):954-60. doi: 10.1001/jamaneurol.2016.1463. JAMA Neurol. 2016. PMID: 27366989
A multicentre randomiSed controlled TRial of IntraVEnous immunoglobulin compared with standard therapy for the treatment of transverse myelitis in adults and children (STRIVE).
Absoud M, Brex P, Ciccarelli O, Diribe O, Giovannoni G, Hellier J, Howe R, Holland R, Kelly J, McCrone P, Murphy C, Palace J, Pickles A, Pike M, Robertson N, Jacob A, Lim M. Absoud M, et al. Among authors: giovannoni g. Health Technol Assess. 2017 May;21(31):1-50. doi: 10.3310/hta21310. Health Technol Assess. 2017. PMID: 28639937 Free PMC article. Clinical Trial.
Vitamin D supplementation.
Dobson R, Cock HR, Brex P, Giovannoni G. Dobson R, et al. Among authors: giovannoni g. Pract Neurol. 2018 Feb;18(1):35-42. doi: 10.1136/practneurol-2017-001720. Epub 2017 Sep 25. Pract Neurol. 2018. PMID: 28947637 Review.
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
Connick P, De Angelis F, Parker RA, Plantone D, Doshi A, John N, Stutters J, MacManus D, Prados Carrasco F, Barkhof F, Ourselin S, Braisher M, Ross M, Cranswick G, Pavitt SH, Giovannoni G, Gandini Wheeler-Kingshott CA, Hawkins C, Sharrack B, Bastow R, Weir CJ, Stallard N, Chandran S, Chataway J; UK Multiple Sclerosis Society Clinical Trials Network. Connick P, et al. Among authors: giovannoni g. BMJ Open. 2018 Aug 30;8(8):e021944. doi: 10.1136/bmjopen-2018-021944. BMJ Open. 2018. PMID: 30166303 Free PMC article. Clinical Trial.
Visibility and representation of women in multiple sclerosis research.
Thomson A, Horne R, Chung C, Marta M, Giovannoni G, Palace J, Dobson R. Thomson A, et al. Among authors: giovannoni g. Neurology. 2019 Apr 9;92(15):713-719. doi: 10.1212/WNL.0000000000007276. Epub 2019 Mar 20. Neurology. 2019. PMID: 30894447 Free PMC article. Review.
Detecting and predicting neutralization of alemtuzumab responses in MS.
Saxena G, Moore JM, Jones M, Pryce G, Ali L, Leisegang GR, Vijay V, Loveless S, Robertson NP, Schmierer K, Giovannoni G, Gnananpavan S, Baker D, Tallantyre EC, Kang AS. Saxena G, et al. Among authors: giovannoni g. Neurol Neuroimmunol Neuroinflamm. 2020 Jun 4;7(4):e767. doi: 10.1212/NXI.0000000000000767. Print 2020 Jul. Neurol Neuroimmunol Neuroinflamm. 2020. PMID: 32499328 Free PMC article.
784 results